EMEA-002861-PIP02-20-M01

Key facts

Invented name
Comirnaty
Active substance
highly purified single-stranded, 5’-capped mRNA encoding full-length SARS-CoV-2 spike protein (BNT162b2)
Therapeutic area
Vaccines
Decision number
P/0179/2021
PIP number
EMEA-002861-PIP02-20-M01
Pharmaceutical form(s)
Concentrate for solution for injection
Condition(s) / indication(s)
Prevention of Coronavirus disease 2019 (COVID-19)
Route(s) of administration
Intramuscular use
Contact for public enquiries
BioNTech Manufacturing GmbH

E-mail: ruben.rizzi@biontech.de

Tel. +49 61319084-7593

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

Related content

How useful was this page?

Add your rating
Average
3 ratings
1 rating
15 ratings